logo

MREO

Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)

MREO fundamentals

Mereo Biopharma (MREO) released its earnings on Nov 10, 2025: revenue was 300.00K (YoY --), missed estimates; EPS was -0.01 (YoY +50.00%), missed estimates.
Revenue / YoY
300.00K
--
EPS / YoY
-0.01
+50.00%
Report date
Nov 10, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Mereo Biopharma (MREO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Mereo Biopharma (MREO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Mereo Biopharma (MREO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Mereo Biopharma (MREO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Mereo Biopharma (MREO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Mereo Biopharma (MREO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield